{"id":"W2891531514","doi":"10.1200/jco.2017.35.15_suppl.8041","title":"Rates of peripheral neuropathy (PN) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM) treated with carfilzomib vs comparators in pivotal phase III trials.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Carfilzomib; Lenalidomide; Internal medicine; Neurotoxicity; Progression-free survival; Multiple myeloma; Bortezomib; Dexamethasone; Refractory (planetary science); Clinical endpoint; Gastroenterology; Oncology; Urology; Toxicity; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004412509,0.0002748883,0.0008350199,0.0003244362,0.000202379,0.0006160438,0.0002750139,0.0005186675,0.001158432],"category_scores_gemma":[0.003327668,0.0001769293,0.001433022,0.0006152106,0.0002000024,0.0005358086,0.0004045875,0.0008451085,0.00009772491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005834386,"about_ca_system_score_gemma":0.0003890288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005369651,"about_ca_topic_score_gemma":0.00138868,"domain_scores_codex":[0.998498,0.0007745929,0.0001818875,0.0002495843,0.000201856,0.00009407054],"domain_scores_gemma":[0.996705,0.001015276,0.001706781,0.00008912065,0.0001013845,0.000382449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.360988,0.001811754,0.4904094,0.001848848,0.009317372,0.0003902327,0.0003308462,0.003503158,0.005336879,0.0002837315,0.004009408,0.1217704],"study_design_scores_gemma":[0.0219739,0.08314291,0.880026,0.000216517,0.004515458,0.001267877,0.000168389,0.002260716,0.001465048,0.0003502822,0.004569973,0.00004290634],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906577,0.007236665,0.0002056664,0.0001557631,0.00003079304,0.0001271161,0.0007343521,0.00001485613,0.00083701],"genre_scores_gemma":[0.9980885,0.0007150442,0.0001295022,0.0001403359,0.0000231576,0.00009332717,0.0006041934,0.000002678127,0.0002032662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004412509,"threshold_uncertainty_score":0.02333581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1527930044340685,"score_gpt":0.4796246044408957,"score_spread":0.3268316000068273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}